SlideShare a Scribd company logo
1 of 34
19.05.15
kemian ja toksikologian tutkimusyksikkö
Multi-residues screening
by UPLC/QTOF
Experts: S.Berg, E.Lindfors, A.Niemi
L.Saari M.Rokka and M. Jestoi
Introduce: J.C.Yorke
19.05.15
kemian ja toksikologian tutkimusyksikkö
Screening process
Extraction process
Clean-up optional
Chromatography
Desolvatation Ionisation
Data acquisition
Data processing
Result
19.05.15
kemian ja toksikologian tutkimusyksikkö
Ultra performance liquid chromatography
• Use of liquid in very high pressure in order to separate
molecules in short and small i.d. column packed with
1,7µm
+ Elution of narrower peak
(increase of peak height decreases detection limit)
+ Increase of peak capacity by 2 or 3 times
(might be helpful to avoid co-elution)
+ Decrease run time of analysis (5-20 min)
- High pressure
- Track of the dead volume (can spoil the separation)
- Few columns (stationary phase) are available
19.05.15
kemian ja toksikologian tutkimusyksikkö
Quadrupole time of flight mass
spectrometer 1/6
Hybrid mass spectrometer coupling a quadrupole to an orthogonal
acceleration time of flight (Q-oa-TOF)
The continuous beam coming from the quad is accelerated by a pulse
applied every 45µs to a pusher plate initiates an orthogonal acceleration.
The ions into the packets have Kinetic energy in relationship with their
masses. The time of flight (TOF) is the time it takes an ion to travel the
length of the flight tube to reach the detector
Mass/charge= AxTOF2
If you inject a compound with a known mass (Lock mass) and
you measure its TOF you obtain A. So you are able to
determine M/z for every ions.
19.05.15
kemian ja toksikologian tutkimusyksikkö
QTOF spectrometer 2/6
QTOF is a“No scanning” instrument allowing:
• MS
• MS/MS
• DDA
MS mode should be the starting point to obtain:
1. Full scan mass acquisition
2. Accurate mass measurement(<5ppm)
3. Enable to obtain spectrum of the molecule
19.05.15
kemian ja toksikologian tutkimusyksikkö
QTOF spectrometer 3/6
Data processing:
Need a heavy data processing
The process can be done “manually”
• Process involves the reconstruction of ion
Chromatograms (narrow extraction window up to 0.01Da)
• Peaks detection
• Comparison of the spectrums obtained from these peaks
with reference spectrums
• Calculation of the mass difference of the unknown with
target component ( should be within 5 ppm)
19.05.15
kemian ja toksikologian tutkimusyksikkö
QTOF spectrometer 4/6
Data processing
The process can be done automatically (need the
purchase of a software- Chromalynx)
We will obtain in that case:
• Raw TIC
• Accurate mass score
• Deconvulated spectrum
• Candidate list (identification of drugs in sample)
19.05.15
kemian ja toksikologian tutkimusyksikkö
Quadrupole time of flight mass
spectrometer 5/6
The use of narrow mass windows in reconstructed ion
chromatograms yields indeed highly selective chromatograms
19.05.15
kemian ja toksikologian tutkimusyksikkö
QTOF spectrometer 6/6
19.05.15
kemian ja toksikologian tutkimusyksikkö
Definition of the project
Develop if possible, one extraction method followed
by UPLC/QTOF for screening veterinary drugs in
animal matrixes
• Should be ideally:
– Rapid
– Robust
– Generic
– Allow retrospective data processing
Might a little too much ideal!
19.05.15
kemian ja toksikologian tutkimusyksikkö
Definition of the project / matrixes
– Evira is currently analysing
the following matrixes
• Tissues ( muscle, liver,
kidney, fish)
• Plasma
• Urine
• Milk
• Eggs
• Honey
• All these analysis are made
with different animal
species
• These analysis are planned
annually in regards to the
national Finnish production
• All the samples are not
available at the same time
Retained matrix
19.05.15
kemian ja toksikologian tutkimusyksikkö
Definition of the project/ drugs
Two types of drugs are analysed with different philosophies
1. Banned substances, group A
Avoid false negative with low false positive at the lowest
detection limit
2. MRL substances, group B
Avoid false positive with precision for the quantification
around the MRL
Remark: The TOF accurate mass measurement is good
tool to identify substances and may be not the best tool
to quantify
19.05.15
kemian ja toksikologian tutkimusyksikkö
Definition of the project/ drugs
Group A
• Stibenes
• Thyreostasts
• Steroid
• Resorcylic acid
• Beta agonists
• Chloramphenicol
• Nitrofurans
• Nitroimidazols
Group B
• Antibacterials
• Tetracyclines
• Beta lactames
• Quinolones
• Sulfa drugs
• Macrolides?
• Anthelmintics
• Anticoccidials
• Carbamates
• Ionophores
• Sedatives
• NSAID
• Organochlorines
• Organophosphorous
• Mycotoxins
• Other pharmacologycally
active substances…
According to detection
capacity of the method
19.05.15
kemian ja toksikologian tutkimusyksikkö
Experimental1/2 work on standard
• We worked on chromatography on standards
– Goal to separated 70 veterinary drugs
– Achieved this separation in a short time
– To have reproducible runs
• Data detection
– Determine for each drug the capacity to be ionised in
electrospray positive or negative mode
– Evaluated the accuracy of the mass measure
– Got spectrums from each drugs
• Data processing
– Extracted ion chromatograms in order to detect peaks
(using Chrotool software)
19.05.15
kemian ja toksikologian tutkimusyksikkö
Experimental 2/2 work on extracts
• Screening process
2 liquid extraction protocols applied to:
• Pork musle tissues blank ( 5 different)
• Pork muscle tissue spiked
– 3 Spiked samples at the concentration of 1µg/g (solution
Nº1 of 45 vet drugs)
– 3 Spiked samples at the concentration of 0,1µg/g
(solution Nº2 of 7 vet drugs)
Evaluation of:
• Selectivity
• Sensivity
• Reproductibility
19.05.15
kemian ja toksikologian tutkimusyksikkö
Chromatography
• Aminoglycosides
• Anthelmintics: Avermectines
• Anthelmintics: Benzimidazoles
• Chloramphenicol
• Antibiotic nitroimidazol
• Antimicrobial,Fumagillin
• Betalactams
• Coccidiostats
• Gestagens
• Glucocorticoid
• Lincosamides
• Micotoxin
• Nitrofurans
• NSAID
• Quinolones
• Sedatives
• Sulfonamides
• Tetracyclines
• Thyreostat
• Triphenylmethan dye
70 Standards from stock solutions have been
evaporated to dry then reconstituted with ACN/Water
50/50 to give concentration from 0,5 to 10 µg/ml, then
injected on 2 columns
19.05.15
kemian ja toksikologian tutkimusyksikkö
Chromatography of 70 standards
drugstd pos 2 HSS T3
Time
2.00 4.00 6.00 8.00 10.00 12.00 14.00 16.00 18.00
%
-10
90
27060704 1: TOF MS ES+
TIC
9.81e5
17.74
773.4830
16.09
528.29668.45
297.08345.02
411.1717
4.33
221.1100
4.06;358.15602.47
128.0452
0.42
263.1457
5.34
425.1861
6.07
311.0804
8.07
331.2182
15.27
282.2798
8.84
329.2003
11.56
387.2532
10.92
309.1583
9.69
404.0904
17.36
773.4783
17.85
693.4185
18.52
747.5059
UPLC Gradient
0
20
40
60
80
100
0 5 10 15 20
RT min
%B(ACN)
19.05.15
kemian ja toksikologian tutkimusyksikkö
Benzimidazoles chromotography
9::0::6
27-Jun-2007
Time
4.50 5.00 5.50 6.00 6.50 7.00 7.50 8.00 8.50 9.00 9.50 10.00
%
-10
90
4.50 5.00 5.50 6.00 6.50 7.00 7.50 8.00 8.50 9.00 9.50 10.00
%
-10
90
4.50 5.00 5.50 6.00 6.50 7.00 7.50 8.00 8.50 9.00 9.50 10.00
%
-10
90
4.50 5.00 5.50 6.00 6.50 7.00 7.50 8.00 8.50 9.00 9.50 10.00
%
-10
90
4.50 5.00 5.50 6.00 6.50 7.00 7.50 8.00 8.50 9.00 9.50 10.00
%
-10
90
27060703 Sm (Mn, 2x3) 1: TOF MS ES+
256.089 0.05Da
4.90e3
Area
5.08
311.0804
520
27060703 Sm (Mn, 2x3) 1: TOF MS ES+
314.094 0.05Da
7.72e3
Area
7.03
314.0944
785
27060703 Sm (Mn, 2x3) 1: TOF MS ES+
332.071 0.05Da
4.91e3
Area
6.51
332.0693
506
27060703 Sm (Mn, 2x3) 1: TOF MS ES+
316.076 0.05Da
3.98e3
Area
5.32
425.1862
427
27060703 Sm (Mn, 2x3) 1: TOF MS ES+
300.081 0.05Da
1.22e4
Area
7.94
300.0806
1295Fenbendazole
Oxfendazole
Oxfendazolesulfone
Flubendazole
Flu Hmet
19.05.15
kemian ja toksikologian tutkimusyksikkö
Benzimidazoles spectrum
drugstd pos 1 HSS T3
m/z
100 150 200 250 300 350 400 450 500 550 600 650 700 750 800 850 900 950 1000
%
0
100
%
0
100
%
0
100
%
0
100
27060703 420 (5.317) 1: TOF MS ES+
5.50e4425.1862
316.0780
126.1277 141.0014 284.0515191.0675
317.0790 377.1829
426.1898
429.1971
873.3531465.1476 762.2374509.1432
!
631.1557
!
561.1458 !
676.2174 778.2191 887.3246
941.2851
27060703 514 (6.511) 1: TOF MS ES+
1.60e4332.0693
100.0754
141.0003 300.0450
198.1846
333.0740
354.0534 685.1174
663.1386
431.9977
!
462.1302
!
518.0734 !
591.3415
!
725.0511
!
787.0052
27060703 555 (7.031) 1: TOF MS ES+
2.00e4314.0944
100.0753
282.0681141.0010
198.1859
315.0961
408.0913336.0805
!
452.0772
!
511.1198
!
690.0926
!
585.1130
!
651.1678
!
718.2329 !
786.3517
!
880.1838
!
917.2204
27060703 401 (5.080) 1: TOF MS ES+
4.75e4311.0804
256.0875
254.0591
156.0112
257.0958 411.1736
312.0835
479.1229
643.1371
501.1063 618.0511
811.1692
675.0737
743.2325
!
843.1137 !
969.1646
Oxfenbendazole
Oxfendazolesulfone
Flubendazole
Flu Hmet
19.05.15
kemian ja toksikologian tutkimusyksikkö
Chromatography
We have not big choice because only few column are
available:
We had tested on standards two apolar columns 2,1mm
x100mm packed with a 1,7µm C18 and HSS T3
Solvent was a linear gradient H2O,HCO2,H, ACN
They were not big differences between the 2 columns
We got nice peak shape with reproducible retention time
No separation was achieved for aminoglycosides
Some problems with Coccidiostats (peak tailing)
19.05.15
kemian ja toksikologian tutkimusyksikkö
Detection
• Nitrofurans as well as Thyreostats were not detected (low
mass drugs)
– Might be due also by a bad tune of the cone voltage for
this drugs
• With the exception of Chloramphenicol and Fumagillin all
the drug were better detected in positive electrospray
ionisation
• With few exception mass measure accuracy was less than
10 ppm
• Quasi molecular ion was not always the biggest peak
• Adduct peaks (Na, K,NH4) as well dimere peak as been
seen
19.05.15
kemian ja toksikologian tutkimusyksikkö
Data acquisition
• Detection of the drug rely on accurate mass measurement
of the drug
Calculation of the molecular weight based on exact masses of the
most abundant natural isotope:
CxHyNzOt
12.011 x + 1.0079 y + 14.0067 z + 15.9994 t
Molecular ion ****
.
****
4 digit after the comma
used for the confirmation of positive
finding as isotopic ratio pattern
In order to be able to record the exact mass of the drug the QTOF
needs to acquire in parallel a lock mass ( we perfuse a compound that
we know the exact mass)
The tune of the instrument is done on this compound
Isotopic ions
19.05.15
kemian ja toksikologian tutkimusyksikkö
Desolvation ionisation
• Detection of the drug if it is ionised
– Rely on parameters:
• UPLC flow, solvents
• Temperatures: source and the gas
• Flow of the gas
• Voltage on electrodes
Mass/Charge
Fragments
Quasi Molecular ion
[Mw+H]+
or [Mw-H] +
Adduc
tions
Dimere
Solvent
Adduct
19.05.15
kemian ja toksikologian tutkimusyksikkö
Chromatography
• Aminoglycosides (No separation)
• Anthelmintics: Avermectines
• Anthelmintics: Benzimidazoles
• Chloramphenicol
• Antibiotic nitroimidazol
• Antimicrobial,Fumagillin
• Betalactams
• Coccidiostats
• Gestagens
• Glucocorticoid
• Lincosamides
• Micotoxin
• Nitrofurans (No detection)
• NSAID
• Quinolones
• Sedatives
• Sulfonamides
• Tetracyclines
• Thyreostat (No detection)
• Triphenylmethan dye
From the 74 drugs we decided to keep 52 drugs
(Not always detected
peak tailing)
19.05.15
kemian ja toksikologian tutkimusyksikkö
Chromatography
• We decided to shorten the retention time from 20
min to 8,5min
– We took a shorter C18 column 50mm instead
of 100 mm
– We change the gradient composition, 2 linear
gradient step
– we change the composition of gradient
19.05.15
kemian ja toksikologian tutkimusyksikkö
RT min % B
0 0
4 30
6 100
7,5 100
UPLC Gradient
0
20
40
60
80
100
0 0,5 1 1,5 2 2,5 3 3,5 4 4,5 5 5,5 6 6,5 7 7,5
RT min
%B(ACN)
Nitroimidazols
Quinolones
Lincosamides
Tetracyclines
Sedative
s
Sulfonamides
Benzimidazoles
Blactams
Triphenylmethandye
NSAID
Avemectines
Chromatography
Screening process/Liquid extraction protocols
PE1, Acid extraction
After an extraction by TCA the
samples are diluted 4,5 times
Weight 2g of minced meat in 15
ml polypropylene tube
Addition of the spiked solution*
(1ml ,90 %water),vortex and wait
15 min
Addition of 8 ml TCA 5%
Stir 10 min 100 rpm
Centrifugation 5min 4000G 10 C
Filtration 1ml 0,45µm
Injection 5µl
PE2, Organic extraction
After an extraction by ACN the samples
are concentrated 2 times
Weight 2g of minced meat in 15 ml
polypropylene tube
Addition of the spiked solution*(1ml ,
90%water),vortex and wait 15 min
Addition of 8 ml ACN
Stir 10 min 100 rpm
Centrifugation 5min 4000G 10 C
Evaporation of 5 ml of the supernatant to
dryness
Reconstituted the sample with 0,5ml
Formic acid 0,1%
Filtration 0,5ml 0,45µm
Injection 5µl
Screening process/results
PE1, Acid extraction
TCA samples are diluted 4,5
times
Clean extract
Increase of retention time due to
high acidity of the sample
Lack of sensitivity due to sample
dilution: 25% of the drugs are
detected
Selectivity not
evaluated
Reproductibility not
evaluated
Spectrums are useless because
of lack of sensitivity
The limit of detection of the Qtof
should be lowered by tuning the
instrument to promote the
ionisation of the drugs
PE2, Organic extraction
ACN samples are concentrated 2
times
Cloudy extract
might need to had a hexane
defating step prior the
evaporation of ACN
No shift of retention time
The narrow windows reconstructed
chromatograms are selective
For most of the drugs the method is
reproducible ( 2 to 17 %)
For most of the drugs the yield of
extraction is around 65 %
Familly Concentration in meat
Concentration
in extract
Recovery
(mean replicate=3)
RSD
extracts ion area
Type
Avermectines
6,46 - 7,09 min
Eprinomectin 0,1µg/g 0,2 µg/ml
standards
not detected
? (M Na)+
Ivermectin 1µg/g 2 µg/ml 64.38% (M Na)+
Doramectin 1µg/g 2 µg/ml 83.08% (M Na)+
Moxidectin 1µg/g 2 µg/ml 77.67% (M Na)+
Benzimidazoles
3,28 - 5,08 min
Fenbendazole 0,1µg/g 0,2 µg/ml 1302.86% 141.67% (M H)+
Oxfendazole 0,1µg/g 0,2 µg/ml 132.12% 24.73% (M H)+
Oxfendazolesulphone 0,1µg/g 0,2 µg/ml 189.74% 90.79% (M H)+
Flubendazole 0,1µg/g 0,2 µg/ml 460.00% 114.43% (M H)+
FLU-HMET 0,1µg/g 0,2 µg/ml 74.84% 74.71% (M H)+
Chloramphenicol
3,71 min
Chloramphenicol 1µg/g 2 µg/ml
standard
not injected
1 injection (M -H)+
Nitroimidazols
1,31- 1,67 min
Ronidazol 1µg/g 2 µg/ml not calculated LD (M H)+
residueHMMNI1µg/g 2 µg/ml 42.65% 10.15% (M H)+
Metronidazol 1µg/g 2 µg/ml 44.14% 6.61% (M H)+
Antimicrobial
5,85 min Fumagillin 1µg/g 2 µg/ml
standard
not injected 1 injection (M -H)+
Betalactams
1,47- 5.25 min
Amoxicillin 1µg/g 2 µg/ml not calculated LD (M Na)+
Ampicillin1µg/g 2 µg/ml 20.83% 14.14% (M Na)+
Benzylpenicillin PeniG 1µg/g 2 µg/ml 52.02% 9.00% (M Na)+
Phenoxymethylpenicillin PeniV 1µg/g 2 µg/ml 53.91% 9.60% (M Na)+
Cefalexin 1µg/g 2 µg/ml 293.33% 3.21% (M Na)+
Oxacillin 1µg/g 2 µg/ml 65.22% 14.40%
(M Na)+
Cloxacillin 1µg/g 2 µg/ml 65.33% 7.64% (M Na)+
Spiked pork meat ( standards290807) extracted ACN
Familly Concentration in meat Concentration
in extract
Recovery
(mean replicate=3)
RSD
extracts ion area
Type
Gestagen
5,92 min Medroxyprogesterone acetate1µg/g 2 µg/ml 503.55% 17.25% (M H)+
Glucocorticoid
4,98 min Dexamethasone1µg/g 2 µg/ml 123.81% 5.44% (M H)+
Lincosamides
2,02 - 3,74 min
Clindamycin1µg/g 2 µg/ml 102.08% 11.61% (M H)+
Lincomycin1µg/g 2 µg/ml 83.06% 6.96% (M H)+
Pirlimycin 1µg/g 2 µg/ml 75.96% 9.59% (M H)+
Mycotoxin 5,52 min Ochratoxin A 1µg/g 2 µg/ml 127.45% 14.49% (M H)+
NSAID
4,56 - 5,83 min
Flunixine1µg/g 2 µg/ml 79.18% 9.22% (M H)+
5-OH-flunixine 0,1µg/g 0,2 µg/ml 54.90% 111.46% (M H)+
Phenylbutazon 1µg/g 2 µg/ml 22.16% 11.25% (M H)+
Oxyphenbutazon Anhydrat1µg/g 2 µg/ml 36.55% 6.16% (M H)+
Quinolones
2,39 - 2,64 min
Enrofloxacin 1µg/g 2 µg/ml 321.23% 7.26% (M H)+
Ciprofloxacin 1µg/g 2 µg/ml 253.04% 8.60% (M H)+
Danofloxacin 1µg/g 2 µg/ml 237.83% 15.14% (M H)+
Sedatives
2,45 - 2,89 min
Azaperone 1µg/g 2 µg/ml 204.08% 13.64% (M H)+
Xylazin 1µg/g 2 µg/ml 74.98% 6.23% (M H)+
Sulfonamides
1,82 - 4,01min
Sulfadimethoxine 1µg/g 2 µg/ml 67.09% 12.50% (M H)+
Sulfadoxine 1µg/g 2 µg/ml 66.40% 10.37% (M H)+
Sulfadiazine 0,5µg/g 1 µg/ml 68.33% 6.90% (M H)+
Sulfamethazine 1µg/g 2 µg/ml 72.21% 1.64% (M H)+
Sulfathiazole 1µg/g 2 µg/ml 67.91% 6.77% (M H)+
Sulfamethoxypyridazine 1µg/g 2 µg/ml 70.12% 7.50% (M H)+
Sulfapyridine 1µg/g 2 µg/ml 66.88% 12.85% (M H)+
Sulfachloropyridazine 1µg/g 2 µg/ml 65.81% 8.16% (M H)+
Sulfisoxazole 1µg/g 2 µg/ml 73.45% 30.29% (M H)+
Sulfamethoxazole 1µg/g 2 µg/ml 71.18% 6.51% (M H)+
Sulfaquinoxaline 0,5µg/g 1 µg/ml 62.50% 10.71% (M H)+
Sulfamerazine 0,5µg/g 1 µg/ml 69.44% 12.55% (M H)+
Tetacyclines
2,36 -3,44 min
Tetracycline 1µg/g 2 µg/ml 41.67% 6.88% (M H)+
Oxytetracycline 1µg/g 2 µg/ml 34.86% 5.68% (M H)+
Chlortetracycline1µg/g 2 µg/ml 30.09% 6.35% (M H)+
Triphenylmethan dye
4,53 - 5,39 min
Malachite green 0,515µg/g 1,03 µg/ml 381.39% 30.61% M +
19.05.15 kemian ja toksikologian tutkimusyksikkö
The avemectines are not detected in the standard solution at 2 µg/ml while they
are detected with a large relative standard deviation in the extract(1µg/g)
The benzimidazoles showed a large relative standard deviation in the extract
and a very high recovery due to may be a problem of ionisation of the extract.
Chloramphenicol and Fumagillin have been detected by ES- in an extract at the
concentration of 1µg/g. The variation of the response of the extracts has not been
evaluated(1 injection) nor the response of the standard (not been injected).
Detection limit should be expected around 10ppb.
Betalactams are detected as sodium adduct in the extracts at 1µg/g (with the
exception of amoxicillin: L.D.).We can hardly expect to see betalactams at100ng/g
because of a loss sensivity. Recovery and RSD are about 60% and 7-15% with
the exception of the cefalexin recovery 300%and 3%. The high recovery of
cefalexin can come by the fact they have less sodium adduct in the standard than
in the extract solution and the calculation is done with the sodium adduct (biggest
peak in the extract samples)
The Medroxyprogesterone acetate is detected in the extracts at 1µg/g. The high
recovery (500%) is not explained the RSD is about 17%.
Interpretation of the results from the extraction of Spiked
pork meat
19.05.15 kemian ja toksikologian tutkimusyksikkö
The dexamethasone is detected in the extracts at 1µg/g. The recovery is 125%
and RSD is 5%. We can hardly expect to see dexamethasone at100ng/g because
of a loss sensivity.
Ochratoxin is detected in the extracts at 1µg/g. The recovery is 125% and RSD
is 15%.
 NSAID are detected in the extracts at 1µg/g. The recovery is 75-102% and RSD
is 7-15%. We can expect to see 50 ng/g .
Quinolones are detected in the extracts at 1µg/g. The recovery is 320-240% and
RSD is 7-11,5%. We can expect to see 10ng/g because the signal is high.
Sulfonamides are detected in the extracts at 1µg/g. The recovery is 62--74% and
RSD is 2-30%. We can expect to see 10ng/g because the signal is high.
Tetracycline are detected in the extracts at 1µg/g. The recovery is 30-41% and
RSD is 7%. We can expect to see 50ng/g .
Triphenylmethan dye are detected in the extracts at 1µg/g. The recovery is
380% and RSD is 30% for Malachite green and 68% and RSD is 22% for
Leucomalachite green. We can expect to see 50ng/g
Interpretation of the results from the extraction of Spiked
pork meat
19.05.15
kemian ja toksikologian tutkimusyksikkö
Improvement of the detection of the drug
• To be able to detect the drug the conditions of ionisation desolvation of
the drug should not be very different from the ones used for the lock
mass.( Hereafter the parameters for our lock Mass: LeucineEnkephalin)
– Capillary (kV) 3.0 -Extraction Cone 3.0
– Sampling Cone 30.0 - Ion Guide3.4
– Source Temperature (°C) 120- Desolvation Temperature (°C)400
– Cone Gas Flow (L/Hr) 20.0
– Desolvation Gas Flow (L/Hr) 1000.0
• The conditions of ionisation of our drugs seem to be much soft
– Sampling Cone 10-25 according to the drug (major parameter can
lead to detection limit 100 higher)
– Ion guide 1-2
Changing of compound for the lock mass
Changing the ion guide voltage
Programming the change of cone voltage in the method
19.05.15
kemian ja toksikologian tutkimusyksikkö
MIX47+6 0.8 ppm I G1.6 SCone(14/0-4min, 30/3.8-8.5min) Scan0.1 IntScan0.02
Time
0.80 0.90 1.00 1.10 1.20 1.30 1.40 1.50 1.60 1.70 1.80 1.90 2.00 2.10
%
-10
90
0.80 0.90 1.00 1.10 1.20 1.30 1.40 1.50 1.60 1.70 1.80 1.90 2.00 2.10
%
-10
90
0.80 0.90 1.00 1.10 1.20 1.30 1.40 1.50 1.60 1.70 1.80 1.90 2.00 2.10
%
-10
90
0.80 0.90 1.00 1.10 1.20 1.30 1.40 1.50 1.60 1.70 1.80 1.90 2.00 2.10
%
-10
90
031007005 Sm (Mn, 3x2) 1: TOF MS ES+
366.112 0.05Da
126
Area
1.48;214.0901;8.31
031007002 Sm (Mn, 3x2) 1: TOF MS ES+
366.112 0.05Da
88.8
Area
1.48;214.0888;5.44
031007005 Sm (Mn, 3x2) 1: TOF MS ES+
388.094 0.05Da
5.64
Area
1.47;214.0901;0.30
031007002 Sm (Mn, 3x2) 1: TOF MS ES+
388.094 0.05Da
6.70
Area
1.49;158.0269;0.41
Amoxocillin
Ion guide 3.4
Amoxocillin
Ion guide 1.6
Amoxocillin Na
Ion guide 1.6
Amoxocillin Na
Ion guide 3.4
+52.7%
-26.8%
Effect of the ion guide voltage on the analyte response

More Related Content

What's hot

Methocarbamol powerpoint final
Methocarbamol powerpoint finalMethocarbamol powerpoint final
Methocarbamol powerpoint finalKasim vali D S
 
Recent control and testing strategies for genotoxic impurities
Recent control and testing strategies for genotoxic impuritiesRecent control and testing strategies for genotoxic impurities
Recent control and testing strategies for genotoxic impuritiesVeeprho Pharmaceuticals Pvt.Ltd
 
Non biopsy diagnosis of acute rejection of Renal allograft
  Non biopsy diagnosis of acute rejection of Renal allograft  Non biopsy diagnosis of acute rejection of Renal allograft
Non biopsy diagnosis of acute rejection of Renal allograftBakshish Singh
 
Quantum pesticide residue detection
Quantum pesticide residue detectionQuantum pesticide residue detection
Quantum pesticide residue detectionJun Steed Huang
 
IOSRPHR(www.iosrphr.org) IOSR Journal of Pharmacy
IOSRPHR(www.iosrphr.org) IOSR Journal of PharmacyIOSRPHR(www.iosrphr.org) IOSR Journal of Pharmacy
IOSRPHR(www.iosrphr.org) IOSR Journal of Pharmacyiosrphr_editor
 
Multi-residue pesticide analysis of food samples using acetonitrile extractio...
Multi-residue pesticide analysis of food samples using acetonitrile extractio...Multi-residue pesticide analysis of food samples using acetonitrile extractio...
Multi-residue pesticide analysis of food samples using acetonitrile extractio...Kate?ina Svobodov
 
Method validation in HPLC of omeprazole enantiomers
Method validation in HPLC of omeprazole enantiomersMethod validation in HPLC of omeprazole enantiomers
Method validation in HPLC of omeprazole enantiomerscoolprashant33
 
Development and validation of method for simultaneous estimation of hydrochlo...
Development and validation of method for simultaneous estimation of hydrochlo...Development and validation of method for simultaneous estimation of hydrochlo...
Development and validation of method for simultaneous estimation of hydrochlo...Ram D Parashar
 
Pharmaceutical analysis, tech & implementation
Pharmaceutical analysis, tech & implementationPharmaceutical analysis, tech & implementation
Pharmaceutical analysis, tech & implementationObydulla (Al Mamun)
 
An Experimental Design Approach for Method Development and Impurity Profiling...
An Experimental Design Approach for Method Development and Impurity Profiling...An Experimental Design Approach for Method Development and Impurity Profiling...
An Experimental Design Approach for Method Development and Impurity Profiling...pharmaindexing
 
Picarro - A Revolution in Food Safety and Food Fraud Detection
Picarro - A Revolution in Food Safety and Food Fraud DetectionPicarro - A Revolution in Food Safety and Food Fraud Detection
Picarro - A Revolution in Food Safety and Food Fraud DetectionPicarro
 
NOVEL SEPARATION AND QUANTITATIVE DETERMINATION OF LEVOFLOXACIN, PRULIFLOXACI...
NOVEL SEPARATION AND QUANTITATIVE DETERMINATION OF LEVOFLOXACIN, PRULIFLOXACI...NOVEL SEPARATION AND QUANTITATIVE DETERMINATION OF LEVOFLOXACIN, PRULIFLOXACI...
NOVEL SEPARATION AND QUANTITATIVE DETERMINATION OF LEVOFLOXACIN, PRULIFLOXACI...Dr. Ravi Sankar
 
Literature survey on method development and validation using UV and HPLC
Literature survey on method development and validation using UV and HPLCLiterature survey on method development and validation using UV and HPLC
Literature survey on method development and validation using UV and HPLCAbhijeet Bhimrao Gaikwad
 
Method development and validation in HPLC
Method development and validation in HPLCMethod development and validation in HPLC
Method development and validation in HPLCcoolprashant33
 

What's hot (20)

Methocarbamol powerpoint final
Methocarbamol powerpoint finalMethocarbamol powerpoint final
Methocarbamol powerpoint final
 
Recent control and testing strategies for genotoxic impurities
Recent control and testing strategies for genotoxic impuritiesRecent control and testing strategies for genotoxic impurities
Recent control and testing strategies for genotoxic impurities
 
Archana B lc ppt
Archana B lc pptArchana B lc ppt
Archana B lc ppt
 
Pesticide residue
Pesticide residuePesticide residue
Pesticide residue
 
Non biopsy diagnosis of acute rejection of Renal allograft
  Non biopsy diagnosis of acute rejection of Renal allograft  Non biopsy diagnosis of acute rejection of Renal allograft
Non biopsy diagnosis of acute rejection of Renal allograft
 
Quantum pesticide residue detection
Quantum pesticide residue detectionQuantum pesticide residue detection
Quantum pesticide residue detection
 
IOSRPHR(www.iosrphr.org) IOSR Journal of Pharmacy
IOSRPHR(www.iosrphr.org) IOSR Journal of PharmacyIOSRPHR(www.iosrphr.org) IOSR Journal of Pharmacy
IOSRPHR(www.iosrphr.org) IOSR Journal of Pharmacy
 
Multi-residue pesticide analysis of food samples using acetonitrile extractio...
Multi-residue pesticide analysis of food samples using acetonitrile extractio...Multi-residue pesticide analysis of food samples using acetonitrile extractio...
Multi-residue pesticide analysis of food samples using acetonitrile extractio...
 
Method validation in HPLC of omeprazole enantiomers
Method validation in HPLC of omeprazole enantiomersMethod validation in HPLC of omeprazole enantiomers
Method validation in HPLC of omeprazole enantiomers
 
Development and validation of method for simultaneous estimation of hydrochlo...
Development and validation of method for simultaneous estimation of hydrochlo...Development and validation of method for simultaneous estimation of hydrochlo...
Development and validation of method for simultaneous estimation of hydrochlo...
 
Pharmaceutical analysis, tech & implementation
Pharmaceutical analysis, tech & implementationPharmaceutical analysis, tech & implementation
Pharmaceutical analysis, tech & implementation
 
An Experimental Design Approach for Method Development and Impurity Profiling...
An Experimental Design Approach for Method Development and Impurity Profiling...An Experimental Design Approach for Method Development and Impurity Profiling...
An Experimental Design Approach for Method Development and Impurity Profiling...
 
Picarro - A Revolution in Food Safety and Food Fraud Detection
Picarro - A Revolution in Food Safety and Food Fraud DetectionPicarro - A Revolution in Food Safety and Food Fraud Detection
Picarro - A Revolution in Food Safety and Food Fraud Detection
 
Bioanalytical ppt
Bioanalytical pptBioanalytical ppt
Bioanalytical ppt
 
Estimation of topiramate by colorimetric method rohit bharti
Estimation of topiramate by colorimetric method  rohit bhartiEstimation of topiramate by colorimetric method  rohit bharti
Estimation of topiramate by colorimetric method rohit bharti
 
NOVEL SEPARATION AND QUANTITATIVE DETERMINATION OF LEVOFLOXACIN, PRULIFLOXACI...
NOVEL SEPARATION AND QUANTITATIVE DETERMINATION OF LEVOFLOXACIN, PRULIFLOXACI...NOVEL SEPARATION AND QUANTITATIVE DETERMINATION OF LEVOFLOXACIN, PRULIFLOXACI...
NOVEL SEPARATION AND QUANTITATIVE DETERMINATION OF LEVOFLOXACIN, PRULIFLOXACI...
 
HPLC: A Nifty tool for Herbal Analysis
HPLC: A Nifty tool for Herbal AnalysisHPLC: A Nifty tool for Herbal Analysis
HPLC: A Nifty tool for Herbal Analysis
 
Sampath
SampathSampath
Sampath
 
Literature survey on method development and validation using UV and HPLC
Literature survey on method development and validation using UV and HPLCLiterature survey on method development and validation using UV and HPLC
Literature survey on method development and validation using UV and HPLC
 
Method development and validation in HPLC
Method development and validation in HPLCMethod development and validation in HPLC
Method development and validation in HPLC
 

Viewers also liked

Using Targeted Resequencing Microarrays for Simultaneous Definitive Detection...
Using Targeted Resequencing Microarrays for Simultaneous Definitive Detection...Using Targeted Resequencing Microarrays for Simultaneous Definitive Detection...
Using Targeted Resequencing Microarrays for Simultaneous Definitive Detection...Agnieszka Caruso
 
2014 lecture next generation metabolic screening - Marrakech
2014 lecture next generation metabolic screening - Marrakech 2014 lecture next generation metabolic screening - Marrakech
2014 lecture next generation metabolic screening - Marrakech Ron Wevers
 
Waters Oligonucleotide Analysis Solutions
Waters Oligonucleotide Analysis SolutionsWaters Oligonucleotide Analysis Solutions
Waters Oligonucleotide Analysis SolutionsWaters Corporation
 
Emit enzyme-multiplied immunoassay technique
Emit   enzyme-multiplied immunoassay techniqueEmit   enzyme-multiplied immunoassay technique
Emit enzyme-multiplied immunoassay technique8304
 
Using LC-MS/MS and Advanced Software Tools to Screen for unknown and Non-targ...
Using LC-MS/MS and Advanced Software Tools to Screen for unknown and Non-targ...Using LC-MS/MS and Advanced Software Tools to Screen for unknown and Non-targ...
Using LC-MS/MS and Advanced Software Tools to Screen for unknown and Non-targ...AB SCIEX India
 
23032015 cult y-camb-organ 1era act
23032015  cult y-camb-organ 1era act23032015  cult y-camb-organ 1era act
23032015 cult y-camb-organ 1era actBartolo Torrealba
 

Viewers also liked (11)

Routine impurity analysis with UPLC/MS and UPC2/MS
Routine impurity analysis with UPLC/MS and UPC2/MSRoutine impurity analysis with UPLC/MS and UPC2/MS
Routine impurity analysis with UPLC/MS and UPC2/MS
 
Using Targeted Resequencing Microarrays for Simultaneous Definitive Detection...
Using Targeted Resequencing Microarrays for Simultaneous Definitive Detection...Using Targeted Resequencing Microarrays for Simultaneous Definitive Detection...
Using Targeted Resequencing Microarrays for Simultaneous Definitive Detection...
 
2014 lecture next generation metabolic screening - Marrakech
2014 lecture next generation metabolic screening - Marrakech 2014 lecture next generation metabolic screening - Marrakech
2014 lecture next generation metabolic screening - Marrakech
 
Waters Oligonucleotide Analysis Solutions
Waters Oligonucleotide Analysis SolutionsWaters Oligonucleotide Analysis Solutions
Waters Oligonucleotide Analysis Solutions
 
Stevia - Analytical LC/MS methods from research to routine - Waters Corporati...
Stevia - Analytical LC/MS methods from research to routine - Waters Corporati...Stevia - Analytical LC/MS methods from research to routine - Waters Corporati...
Stevia - Analytical LC/MS methods from research to routine - Waters Corporati...
 
Workplace Drug Screening Using Liquid Chromatography-Tandem Mass Spectrometry...
Workplace Drug Screening Using Liquid Chromatography-Tandem Mass Spectrometry...Workplace Drug Screening Using Liquid Chromatography-Tandem Mass Spectrometry...
Workplace Drug Screening Using Liquid Chromatography-Tandem Mass Spectrometry...
 
Overview of Food Allergen Detection using Mass Spectrometry - Waters Corporat...
Overview of Food Allergen Detection using Mass Spectrometry - Waters Corporat...Overview of Food Allergen Detection using Mass Spectrometry - Waters Corporat...
Overview of Food Allergen Detection using Mass Spectrometry - Waters Corporat...
 
Emit enzyme-multiplied immunoassay technique
Emit   enzyme-multiplied immunoassay techniqueEmit   enzyme-multiplied immunoassay technique
Emit enzyme-multiplied immunoassay technique
 
Using LC-MS/MS and Advanced Software Tools to Screen for unknown and Non-targ...
Using LC-MS/MS and Advanced Software Tools to Screen for unknown and Non-targ...Using LC-MS/MS and Advanced Software Tools to Screen for unknown and Non-targ...
Using LC-MS/MS and Advanced Software Tools to Screen for unknown and Non-targ...
 
23032015 cult y-camb-organ 1era act
23032015  cult y-camb-organ 1era act23032015  cult y-camb-organ 1era act
23032015 cult y-camb-organ 1era act
 
Slideshare ppt
Slideshare pptSlideshare ppt
Slideshare ppt
 

Similar to qtofmultiresidues2

metabolomics_techniques_approaches_methods
metabolomics_techniques_approaches_methodsmetabolomics_techniques_approaches_methods
metabolomics_techniques_approaches_methodsSachin Teotia
 
semester4paper4forensic-170226082103.pdf
semester4paper4forensic-170226082103.pdfsemester4paper4forensic-170226082103.pdf
semester4paper4forensic-170226082103.pdfChijiokeNsofor
 
Validated Pain Management Drugs in Urine-MicroLiter
Validated Pain Management Drugs in Urine-MicroLiterValidated Pain Management Drugs in Urine-MicroLiter
Validated Pain Management Drugs in Urine-MicroLiterRick Youngblood
 
Different Laboratory Equipment used in Toxicology and Molecular Biology
Different Laboratory Equipment used in Toxicology and Molecular BiologyDifferent Laboratory Equipment used in Toxicology and Molecular Biology
Different Laboratory Equipment used in Toxicology and Molecular BiologyMuhammad Kamran (Sial)
 
Marini Electro 2006
Marini Electro 2006Marini Electro 2006
Marini Electro 2006Jalal Hawari
 
"Productivity and Simplicity" - Streamlining Cumbersome Sample Preparation i...
"Productivity and Simplicity" -  Streamlining Cumbersome Sample Preparation i..."Productivity and Simplicity" -  Streamlining Cumbersome Sample Preparation i...
"Productivity and Simplicity" - Streamlining Cumbersome Sample Preparation i...Oscar Cabrices PhD
 
attachment3654CA09
attachment3654CA09attachment3654CA09
attachment3654CA09Ruiqi Hu
 
5-MEO-DALT produces short-lived psychedelic effects
5-MEO-DALT produces short-lived psychedelic effects5-MEO-DALT produces short-lived psychedelic effects
5-MEO-DALT produces short-lived psychedelic effectsBRC SHOP
 
zidovudine hplc method
zidovudine hplc method zidovudine hplc method
zidovudine hplc method Aparna Rajeevi
 
20160219 - M. Agostini - Nuove tecnologie per lo studio del DNA tumorale libe...
20160219 - M. Agostini - Nuove tecnologie per lo studio del DNA tumorale libe...20160219 - M. Agostini - Nuove tecnologie per lo studio del DNA tumorale libe...
20160219 - M. Agostini - Nuove tecnologie per lo studio del DNA tumorale libe...Roberto Scarafia
 
advance phytochemical analysis.pptx
advance phytochemical analysis.pptxadvance phytochemical analysis.pptx
advance phytochemical analysis.pptxPratikKapse8
 
Formulation and Evaluation of Immediate Release Tablet for Treatment of Overa...
Formulation and Evaluation of Immediate Release Tablet for Treatment of Overa...Formulation and Evaluation of Immediate Release Tablet for Treatment of Overa...
Formulation and Evaluation of Immediate Release Tablet for Treatment of Overa...BhuminJain1
 

Similar to qtofmultiresidues2 (20)

pesticide residue analysis methods in fruits and vegetables
pesticide residue analysis methods in fruits and vegetablespesticide residue analysis methods in fruits and vegetables
pesticide residue analysis methods in fruits and vegetables
 
Metabolomics
MetabolomicsMetabolomics
Metabolomics
 
metabolomics_techniques_approaches_methods
metabolomics_techniques_approaches_methodsmetabolomics_techniques_approaches_methods
metabolomics_techniques_approaches_methods
 
semester4paper4forensic-170226082103.pdf
semester4paper4forensic-170226082103.pdfsemester4paper4forensic-170226082103.pdf
semester4paper4forensic-170226082103.pdf
 
Validated Pain Management Drugs in Urine-MicroLiter
Validated Pain Management Drugs in Urine-MicroLiterValidated Pain Management Drugs in Urine-MicroLiter
Validated Pain Management Drugs in Urine-MicroLiter
 
Different Laboratory Equipment used in Toxicology and Molecular Biology
Different Laboratory Equipment used in Toxicology and Molecular BiologyDifferent Laboratory Equipment used in Toxicology and Molecular Biology
Different Laboratory Equipment used in Toxicology and Molecular Biology
 
Hyphenated techniques
Hyphenated techniquesHyphenated techniques
Hyphenated techniques
 
Qc
QcQc
Qc
 
Marini Electro 2006
Marini Electro 2006Marini Electro 2006
Marini Electro 2006
 
"Productivity and Simplicity" - Streamlining Cumbersome Sample Preparation i...
"Productivity and Simplicity" -  Streamlining Cumbersome Sample Preparation i..."Productivity and Simplicity" -  Streamlining Cumbersome Sample Preparation i...
"Productivity and Simplicity" - Streamlining Cumbersome Sample Preparation i...
 
attachment3654CA09
attachment3654CA09attachment3654CA09
attachment3654CA09
 
5-MEO-DALT produces short-lived psychedelic effects
5-MEO-DALT produces short-lived psychedelic effects5-MEO-DALT produces short-lived psychedelic effects
5-MEO-DALT produces short-lived psychedelic effects
 
ANALYTICAL.ppt
ANALYTICAL.pptANALYTICAL.ppt
ANALYTICAL.ppt
 
zidovudine hplc method
zidovudine hplc method zidovudine hplc method
zidovudine hplc method
 
Automated Urine Analysis
Automated Urine AnalysisAutomated Urine Analysis
Automated Urine Analysis
 
20160219 - M. Agostini - Nuove tecnologie per lo studio del DNA tumorale libe...
20160219 - M. Agostini - Nuove tecnologie per lo studio del DNA tumorale libe...20160219 - M. Agostini - Nuove tecnologie per lo studio del DNA tumorale libe...
20160219 - M. Agostini - Nuove tecnologie per lo studio del DNA tumorale libe...
 
advance phytochemical analysis.pptx
advance phytochemical analysis.pptxadvance phytochemical analysis.pptx
advance phytochemical analysis.pptx
 
Formulation and Evaluation of Immediate Release Tablet for Treatment of Overa...
Formulation and Evaluation of Immediate Release Tablet for Treatment of Overa...Formulation and Evaluation of Immediate Release Tablet for Treatment of Overa...
Formulation and Evaluation of Immediate Release Tablet for Treatment of Overa...
 
Anna-Maria Hogan
Anna-Maria HoganAnna-Maria Hogan
Anna-Maria Hogan
 
Tb newer diagnostics
Tb newer diagnosticsTb newer diagnostics
Tb newer diagnostics
 

qtofmultiresidues2

  • 1. 19.05.15 kemian ja toksikologian tutkimusyksikkö Multi-residues screening by UPLC/QTOF Experts: S.Berg, E.Lindfors, A.Niemi L.Saari M.Rokka and M. Jestoi Introduce: J.C.Yorke
  • 2. 19.05.15 kemian ja toksikologian tutkimusyksikkö Screening process Extraction process Clean-up optional Chromatography Desolvatation Ionisation Data acquisition Data processing Result
  • 3. 19.05.15 kemian ja toksikologian tutkimusyksikkö Ultra performance liquid chromatography • Use of liquid in very high pressure in order to separate molecules in short and small i.d. column packed with 1,7µm + Elution of narrower peak (increase of peak height decreases detection limit) + Increase of peak capacity by 2 or 3 times (might be helpful to avoid co-elution) + Decrease run time of analysis (5-20 min) - High pressure - Track of the dead volume (can spoil the separation) - Few columns (stationary phase) are available
  • 4. 19.05.15 kemian ja toksikologian tutkimusyksikkö Quadrupole time of flight mass spectrometer 1/6 Hybrid mass spectrometer coupling a quadrupole to an orthogonal acceleration time of flight (Q-oa-TOF) The continuous beam coming from the quad is accelerated by a pulse applied every 45µs to a pusher plate initiates an orthogonal acceleration. The ions into the packets have Kinetic energy in relationship with their masses. The time of flight (TOF) is the time it takes an ion to travel the length of the flight tube to reach the detector Mass/charge= AxTOF2 If you inject a compound with a known mass (Lock mass) and you measure its TOF you obtain A. So you are able to determine M/z for every ions.
  • 5. 19.05.15 kemian ja toksikologian tutkimusyksikkö QTOF spectrometer 2/6 QTOF is a“No scanning” instrument allowing: • MS • MS/MS • DDA MS mode should be the starting point to obtain: 1. Full scan mass acquisition 2. Accurate mass measurement(<5ppm) 3. Enable to obtain spectrum of the molecule
  • 6. 19.05.15 kemian ja toksikologian tutkimusyksikkö QTOF spectrometer 3/6 Data processing: Need a heavy data processing The process can be done “manually” • Process involves the reconstruction of ion Chromatograms (narrow extraction window up to 0.01Da) • Peaks detection • Comparison of the spectrums obtained from these peaks with reference spectrums • Calculation of the mass difference of the unknown with target component ( should be within 5 ppm)
  • 7. 19.05.15 kemian ja toksikologian tutkimusyksikkö QTOF spectrometer 4/6 Data processing The process can be done automatically (need the purchase of a software- Chromalynx) We will obtain in that case: • Raw TIC • Accurate mass score • Deconvulated spectrum • Candidate list (identification of drugs in sample)
  • 8. 19.05.15 kemian ja toksikologian tutkimusyksikkö Quadrupole time of flight mass spectrometer 5/6 The use of narrow mass windows in reconstructed ion chromatograms yields indeed highly selective chromatograms
  • 9. 19.05.15 kemian ja toksikologian tutkimusyksikkö QTOF spectrometer 6/6
  • 10. 19.05.15 kemian ja toksikologian tutkimusyksikkö Definition of the project Develop if possible, one extraction method followed by UPLC/QTOF for screening veterinary drugs in animal matrixes • Should be ideally: – Rapid – Robust – Generic – Allow retrospective data processing Might a little too much ideal!
  • 11. 19.05.15 kemian ja toksikologian tutkimusyksikkö Definition of the project / matrixes – Evira is currently analysing the following matrixes • Tissues ( muscle, liver, kidney, fish) • Plasma • Urine • Milk • Eggs • Honey • All these analysis are made with different animal species • These analysis are planned annually in regards to the national Finnish production • All the samples are not available at the same time Retained matrix
  • 12. 19.05.15 kemian ja toksikologian tutkimusyksikkö Definition of the project/ drugs Two types of drugs are analysed with different philosophies 1. Banned substances, group A Avoid false negative with low false positive at the lowest detection limit 2. MRL substances, group B Avoid false positive with precision for the quantification around the MRL Remark: The TOF accurate mass measurement is good tool to identify substances and may be not the best tool to quantify
  • 13. 19.05.15 kemian ja toksikologian tutkimusyksikkö Definition of the project/ drugs Group A • Stibenes • Thyreostasts • Steroid • Resorcylic acid • Beta agonists • Chloramphenicol • Nitrofurans • Nitroimidazols Group B • Antibacterials • Tetracyclines • Beta lactames • Quinolones • Sulfa drugs • Macrolides? • Anthelmintics • Anticoccidials • Carbamates • Ionophores • Sedatives • NSAID • Organochlorines • Organophosphorous • Mycotoxins • Other pharmacologycally active substances… According to detection capacity of the method
  • 14. 19.05.15 kemian ja toksikologian tutkimusyksikkö Experimental1/2 work on standard • We worked on chromatography on standards – Goal to separated 70 veterinary drugs – Achieved this separation in a short time – To have reproducible runs • Data detection – Determine for each drug the capacity to be ionised in electrospray positive or negative mode – Evaluated the accuracy of the mass measure – Got spectrums from each drugs • Data processing – Extracted ion chromatograms in order to detect peaks (using Chrotool software)
  • 15. 19.05.15 kemian ja toksikologian tutkimusyksikkö Experimental 2/2 work on extracts • Screening process 2 liquid extraction protocols applied to: • Pork musle tissues blank ( 5 different) • Pork muscle tissue spiked – 3 Spiked samples at the concentration of 1µg/g (solution Nº1 of 45 vet drugs) – 3 Spiked samples at the concentration of 0,1µg/g (solution Nº2 of 7 vet drugs) Evaluation of: • Selectivity • Sensivity • Reproductibility
  • 16. 19.05.15 kemian ja toksikologian tutkimusyksikkö Chromatography • Aminoglycosides • Anthelmintics: Avermectines • Anthelmintics: Benzimidazoles • Chloramphenicol • Antibiotic nitroimidazol • Antimicrobial,Fumagillin • Betalactams • Coccidiostats • Gestagens • Glucocorticoid • Lincosamides • Micotoxin • Nitrofurans • NSAID • Quinolones • Sedatives • Sulfonamides • Tetracyclines • Thyreostat • Triphenylmethan dye 70 Standards from stock solutions have been evaporated to dry then reconstituted with ACN/Water 50/50 to give concentration from 0,5 to 10 µg/ml, then injected on 2 columns
  • 17. 19.05.15 kemian ja toksikologian tutkimusyksikkö Chromatography of 70 standards drugstd pos 2 HSS T3 Time 2.00 4.00 6.00 8.00 10.00 12.00 14.00 16.00 18.00 % -10 90 27060704 1: TOF MS ES+ TIC 9.81e5 17.74 773.4830 16.09 528.29668.45 297.08345.02 411.1717 4.33 221.1100 4.06;358.15602.47 128.0452 0.42 263.1457 5.34 425.1861 6.07 311.0804 8.07 331.2182 15.27 282.2798 8.84 329.2003 11.56 387.2532 10.92 309.1583 9.69 404.0904 17.36 773.4783 17.85 693.4185 18.52 747.5059 UPLC Gradient 0 20 40 60 80 100 0 5 10 15 20 RT min %B(ACN)
  • 18. 19.05.15 kemian ja toksikologian tutkimusyksikkö Benzimidazoles chromotography 9::0::6 27-Jun-2007 Time 4.50 5.00 5.50 6.00 6.50 7.00 7.50 8.00 8.50 9.00 9.50 10.00 % -10 90 4.50 5.00 5.50 6.00 6.50 7.00 7.50 8.00 8.50 9.00 9.50 10.00 % -10 90 4.50 5.00 5.50 6.00 6.50 7.00 7.50 8.00 8.50 9.00 9.50 10.00 % -10 90 4.50 5.00 5.50 6.00 6.50 7.00 7.50 8.00 8.50 9.00 9.50 10.00 % -10 90 4.50 5.00 5.50 6.00 6.50 7.00 7.50 8.00 8.50 9.00 9.50 10.00 % -10 90 27060703 Sm (Mn, 2x3) 1: TOF MS ES+ 256.089 0.05Da 4.90e3 Area 5.08 311.0804 520 27060703 Sm (Mn, 2x3) 1: TOF MS ES+ 314.094 0.05Da 7.72e3 Area 7.03 314.0944 785 27060703 Sm (Mn, 2x3) 1: TOF MS ES+ 332.071 0.05Da 4.91e3 Area 6.51 332.0693 506 27060703 Sm (Mn, 2x3) 1: TOF MS ES+ 316.076 0.05Da 3.98e3 Area 5.32 425.1862 427 27060703 Sm (Mn, 2x3) 1: TOF MS ES+ 300.081 0.05Da 1.22e4 Area 7.94 300.0806 1295Fenbendazole Oxfendazole Oxfendazolesulfone Flubendazole Flu Hmet
  • 19. 19.05.15 kemian ja toksikologian tutkimusyksikkö Benzimidazoles spectrum drugstd pos 1 HSS T3 m/z 100 150 200 250 300 350 400 450 500 550 600 650 700 750 800 850 900 950 1000 % 0 100 % 0 100 % 0 100 % 0 100 27060703 420 (5.317) 1: TOF MS ES+ 5.50e4425.1862 316.0780 126.1277 141.0014 284.0515191.0675 317.0790 377.1829 426.1898 429.1971 873.3531465.1476 762.2374509.1432 ! 631.1557 ! 561.1458 ! 676.2174 778.2191 887.3246 941.2851 27060703 514 (6.511) 1: TOF MS ES+ 1.60e4332.0693 100.0754 141.0003 300.0450 198.1846 333.0740 354.0534 685.1174 663.1386 431.9977 ! 462.1302 ! 518.0734 ! 591.3415 ! 725.0511 ! 787.0052 27060703 555 (7.031) 1: TOF MS ES+ 2.00e4314.0944 100.0753 282.0681141.0010 198.1859 315.0961 408.0913336.0805 ! 452.0772 ! 511.1198 ! 690.0926 ! 585.1130 ! 651.1678 ! 718.2329 ! 786.3517 ! 880.1838 ! 917.2204 27060703 401 (5.080) 1: TOF MS ES+ 4.75e4311.0804 256.0875 254.0591 156.0112 257.0958 411.1736 312.0835 479.1229 643.1371 501.1063 618.0511 811.1692 675.0737 743.2325 ! 843.1137 ! 969.1646 Oxfenbendazole Oxfendazolesulfone Flubendazole Flu Hmet
  • 20. 19.05.15 kemian ja toksikologian tutkimusyksikkö Chromatography We have not big choice because only few column are available: We had tested on standards two apolar columns 2,1mm x100mm packed with a 1,7µm C18 and HSS T3 Solvent was a linear gradient H2O,HCO2,H, ACN They were not big differences between the 2 columns We got nice peak shape with reproducible retention time No separation was achieved for aminoglycosides Some problems with Coccidiostats (peak tailing)
  • 21. 19.05.15 kemian ja toksikologian tutkimusyksikkö Detection • Nitrofurans as well as Thyreostats were not detected (low mass drugs) – Might be due also by a bad tune of the cone voltage for this drugs • With the exception of Chloramphenicol and Fumagillin all the drug were better detected in positive electrospray ionisation • With few exception mass measure accuracy was less than 10 ppm • Quasi molecular ion was not always the biggest peak • Adduct peaks (Na, K,NH4) as well dimere peak as been seen
  • 22. 19.05.15 kemian ja toksikologian tutkimusyksikkö Data acquisition • Detection of the drug rely on accurate mass measurement of the drug Calculation of the molecular weight based on exact masses of the most abundant natural isotope: CxHyNzOt 12.011 x + 1.0079 y + 14.0067 z + 15.9994 t Molecular ion **** . **** 4 digit after the comma used for the confirmation of positive finding as isotopic ratio pattern In order to be able to record the exact mass of the drug the QTOF needs to acquire in parallel a lock mass ( we perfuse a compound that we know the exact mass) The tune of the instrument is done on this compound Isotopic ions
  • 23. 19.05.15 kemian ja toksikologian tutkimusyksikkö Desolvation ionisation • Detection of the drug if it is ionised – Rely on parameters: • UPLC flow, solvents • Temperatures: source and the gas • Flow of the gas • Voltage on electrodes Mass/Charge Fragments Quasi Molecular ion [Mw+H]+ or [Mw-H] + Adduc tions Dimere Solvent Adduct
  • 24. 19.05.15 kemian ja toksikologian tutkimusyksikkö Chromatography • Aminoglycosides (No separation) • Anthelmintics: Avermectines • Anthelmintics: Benzimidazoles • Chloramphenicol • Antibiotic nitroimidazol • Antimicrobial,Fumagillin • Betalactams • Coccidiostats • Gestagens • Glucocorticoid • Lincosamides • Micotoxin • Nitrofurans (No detection) • NSAID • Quinolones • Sedatives • Sulfonamides • Tetracyclines • Thyreostat (No detection) • Triphenylmethan dye From the 74 drugs we decided to keep 52 drugs (Not always detected peak tailing)
  • 25. 19.05.15 kemian ja toksikologian tutkimusyksikkö Chromatography • We decided to shorten the retention time from 20 min to 8,5min – We took a shorter C18 column 50mm instead of 100 mm – We change the gradient composition, 2 linear gradient step – we change the composition of gradient
  • 26. 19.05.15 kemian ja toksikologian tutkimusyksikkö RT min % B 0 0 4 30 6 100 7,5 100 UPLC Gradient 0 20 40 60 80 100 0 0,5 1 1,5 2 2,5 3 3,5 4 4,5 5 5,5 6 6,5 7 7,5 RT min %B(ACN) Nitroimidazols Quinolones Lincosamides Tetracyclines Sedative s Sulfonamides Benzimidazoles Blactams Triphenylmethandye NSAID Avemectines Chromatography
  • 27. Screening process/Liquid extraction protocols PE1, Acid extraction After an extraction by TCA the samples are diluted 4,5 times Weight 2g of minced meat in 15 ml polypropylene tube Addition of the spiked solution* (1ml ,90 %water),vortex and wait 15 min Addition of 8 ml TCA 5% Stir 10 min 100 rpm Centrifugation 5min 4000G 10 C Filtration 1ml 0,45µm Injection 5µl PE2, Organic extraction After an extraction by ACN the samples are concentrated 2 times Weight 2g of minced meat in 15 ml polypropylene tube Addition of the spiked solution*(1ml , 90%water),vortex and wait 15 min Addition of 8 ml ACN Stir 10 min 100 rpm Centrifugation 5min 4000G 10 C Evaporation of 5 ml of the supernatant to dryness Reconstituted the sample with 0,5ml Formic acid 0,1% Filtration 0,5ml 0,45µm Injection 5µl
  • 28. Screening process/results PE1, Acid extraction TCA samples are diluted 4,5 times Clean extract Increase of retention time due to high acidity of the sample Lack of sensitivity due to sample dilution: 25% of the drugs are detected Selectivity not evaluated Reproductibility not evaluated Spectrums are useless because of lack of sensitivity The limit of detection of the Qtof should be lowered by tuning the instrument to promote the ionisation of the drugs PE2, Organic extraction ACN samples are concentrated 2 times Cloudy extract might need to had a hexane defating step prior the evaporation of ACN No shift of retention time The narrow windows reconstructed chromatograms are selective For most of the drugs the method is reproducible ( 2 to 17 %) For most of the drugs the yield of extraction is around 65 %
  • 29. Familly Concentration in meat Concentration in extract Recovery (mean replicate=3) RSD extracts ion area Type Avermectines 6,46 - 7,09 min Eprinomectin 0,1µg/g 0,2 µg/ml standards not detected ? (M Na)+ Ivermectin 1µg/g 2 µg/ml 64.38% (M Na)+ Doramectin 1µg/g 2 µg/ml 83.08% (M Na)+ Moxidectin 1µg/g 2 µg/ml 77.67% (M Na)+ Benzimidazoles 3,28 - 5,08 min Fenbendazole 0,1µg/g 0,2 µg/ml 1302.86% 141.67% (M H)+ Oxfendazole 0,1µg/g 0,2 µg/ml 132.12% 24.73% (M H)+ Oxfendazolesulphone 0,1µg/g 0,2 µg/ml 189.74% 90.79% (M H)+ Flubendazole 0,1µg/g 0,2 µg/ml 460.00% 114.43% (M H)+ FLU-HMET 0,1µg/g 0,2 µg/ml 74.84% 74.71% (M H)+ Chloramphenicol 3,71 min Chloramphenicol 1µg/g 2 µg/ml standard not injected 1 injection (M -H)+ Nitroimidazols 1,31- 1,67 min Ronidazol 1µg/g 2 µg/ml not calculated LD (M H)+ residueHMMNI1µg/g 2 µg/ml 42.65% 10.15% (M H)+ Metronidazol 1µg/g 2 µg/ml 44.14% 6.61% (M H)+ Antimicrobial 5,85 min Fumagillin 1µg/g 2 µg/ml standard not injected 1 injection (M -H)+ Betalactams 1,47- 5.25 min Amoxicillin 1µg/g 2 µg/ml not calculated LD (M Na)+ Ampicillin1µg/g 2 µg/ml 20.83% 14.14% (M Na)+ Benzylpenicillin PeniG 1µg/g 2 µg/ml 52.02% 9.00% (M Na)+ Phenoxymethylpenicillin PeniV 1µg/g 2 µg/ml 53.91% 9.60% (M Na)+ Cefalexin 1µg/g 2 µg/ml 293.33% 3.21% (M Na)+ Oxacillin 1µg/g 2 µg/ml 65.22% 14.40% (M Na)+ Cloxacillin 1µg/g 2 µg/ml 65.33% 7.64% (M Na)+ Spiked pork meat ( standards290807) extracted ACN
  • 30. Familly Concentration in meat Concentration in extract Recovery (mean replicate=3) RSD extracts ion area Type Gestagen 5,92 min Medroxyprogesterone acetate1µg/g 2 µg/ml 503.55% 17.25% (M H)+ Glucocorticoid 4,98 min Dexamethasone1µg/g 2 µg/ml 123.81% 5.44% (M H)+ Lincosamides 2,02 - 3,74 min Clindamycin1µg/g 2 µg/ml 102.08% 11.61% (M H)+ Lincomycin1µg/g 2 µg/ml 83.06% 6.96% (M H)+ Pirlimycin 1µg/g 2 µg/ml 75.96% 9.59% (M H)+ Mycotoxin 5,52 min Ochratoxin A 1µg/g 2 µg/ml 127.45% 14.49% (M H)+ NSAID 4,56 - 5,83 min Flunixine1µg/g 2 µg/ml 79.18% 9.22% (M H)+ 5-OH-flunixine 0,1µg/g 0,2 µg/ml 54.90% 111.46% (M H)+ Phenylbutazon 1µg/g 2 µg/ml 22.16% 11.25% (M H)+ Oxyphenbutazon Anhydrat1µg/g 2 µg/ml 36.55% 6.16% (M H)+ Quinolones 2,39 - 2,64 min Enrofloxacin 1µg/g 2 µg/ml 321.23% 7.26% (M H)+ Ciprofloxacin 1µg/g 2 µg/ml 253.04% 8.60% (M H)+ Danofloxacin 1µg/g 2 µg/ml 237.83% 15.14% (M H)+ Sedatives 2,45 - 2,89 min Azaperone 1µg/g 2 µg/ml 204.08% 13.64% (M H)+ Xylazin 1µg/g 2 µg/ml 74.98% 6.23% (M H)+ Sulfonamides 1,82 - 4,01min Sulfadimethoxine 1µg/g 2 µg/ml 67.09% 12.50% (M H)+ Sulfadoxine 1µg/g 2 µg/ml 66.40% 10.37% (M H)+ Sulfadiazine 0,5µg/g 1 µg/ml 68.33% 6.90% (M H)+ Sulfamethazine 1µg/g 2 µg/ml 72.21% 1.64% (M H)+ Sulfathiazole 1µg/g 2 µg/ml 67.91% 6.77% (M H)+ Sulfamethoxypyridazine 1µg/g 2 µg/ml 70.12% 7.50% (M H)+ Sulfapyridine 1µg/g 2 µg/ml 66.88% 12.85% (M H)+ Sulfachloropyridazine 1µg/g 2 µg/ml 65.81% 8.16% (M H)+ Sulfisoxazole 1µg/g 2 µg/ml 73.45% 30.29% (M H)+ Sulfamethoxazole 1µg/g 2 µg/ml 71.18% 6.51% (M H)+ Sulfaquinoxaline 0,5µg/g 1 µg/ml 62.50% 10.71% (M H)+ Sulfamerazine 0,5µg/g 1 µg/ml 69.44% 12.55% (M H)+ Tetacyclines 2,36 -3,44 min Tetracycline 1µg/g 2 µg/ml 41.67% 6.88% (M H)+ Oxytetracycline 1µg/g 2 µg/ml 34.86% 5.68% (M H)+ Chlortetracycline1µg/g 2 µg/ml 30.09% 6.35% (M H)+ Triphenylmethan dye 4,53 - 5,39 min Malachite green 0,515µg/g 1,03 µg/ml 381.39% 30.61% M +
  • 31. 19.05.15 kemian ja toksikologian tutkimusyksikkö The avemectines are not detected in the standard solution at 2 µg/ml while they are detected with a large relative standard deviation in the extract(1µg/g) The benzimidazoles showed a large relative standard deviation in the extract and a very high recovery due to may be a problem of ionisation of the extract. Chloramphenicol and Fumagillin have been detected by ES- in an extract at the concentration of 1µg/g. The variation of the response of the extracts has not been evaluated(1 injection) nor the response of the standard (not been injected). Detection limit should be expected around 10ppb. Betalactams are detected as sodium adduct in the extracts at 1µg/g (with the exception of amoxicillin: L.D.).We can hardly expect to see betalactams at100ng/g because of a loss sensivity. Recovery and RSD are about 60% and 7-15% with the exception of the cefalexin recovery 300%and 3%. The high recovery of cefalexin can come by the fact they have less sodium adduct in the standard than in the extract solution and the calculation is done with the sodium adduct (biggest peak in the extract samples) The Medroxyprogesterone acetate is detected in the extracts at 1µg/g. The high recovery (500%) is not explained the RSD is about 17%. Interpretation of the results from the extraction of Spiked pork meat
  • 32. 19.05.15 kemian ja toksikologian tutkimusyksikkö The dexamethasone is detected in the extracts at 1µg/g. The recovery is 125% and RSD is 5%. We can hardly expect to see dexamethasone at100ng/g because of a loss sensivity. Ochratoxin is detected in the extracts at 1µg/g. The recovery is 125% and RSD is 15%.  NSAID are detected in the extracts at 1µg/g. The recovery is 75-102% and RSD is 7-15%. We can expect to see 50 ng/g . Quinolones are detected in the extracts at 1µg/g. The recovery is 320-240% and RSD is 7-11,5%. We can expect to see 10ng/g because the signal is high. Sulfonamides are detected in the extracts at 1µg/g. The recovery is 62--74% and RSD is 2-30%. We can expect to see 10ng/g because the signal is high. Tetracycline are detected in the extracts at 1µg/g. The recovery is 30-41% and RSD is 7%. We can expect to see 50ng/g . Triphenylmethan dye are detected in the extracts at 1µg/g. The recovery is 380% and RSD is 30% for Malachite green and 68% and RSD is 22% for Leucomalachite green. We can expect to see 50ng/g Interpretation of the results from the extraction of Spiked pork meat
  • 33. 19.05.15 kemian ja toksikologian tutkimusyksikkö Improvement of the detection of the drug • To be able to detect the drug the conditions of ionisation desolvation of the drug should not be very different from the ones used for the lock mass.( Hereafter the parameters for our lock Mass: LeucineEnkephalin) – Capillary (kV) 3.0 -Extraction Cone 3.0 – Sampling Cone 30.0 - Ion Guide3.4 – Source Temperature (°C) 120- Desolvation Temperature (°C)400 – Cone Gas Flow (L/Hr) 20.0 – Desolvation Gas Flow (L/Hr) 1000.0 • The conditions of ionisation of our drugs seem to be much soft – Sampling Cone 10-25 according to the drug (major parameter can lead to detection limit 100 higher) – Ion guide 1-2 Changing of compound for the lock mass Changing the ion guide voltage Programming the change of cone voltage in the method
  • 34. 19.05.15 kemian ja toksikologian tutkimusyksikkö MIX47+6 0.8 ppm I G1.6 SCone(14/0-4min, 30/3.8-8.5min) Scan0.1 IntScan0.02 Time 0.80 0.90 1.00 1.10 1.20 1.30 1.40 1.50 1.60 1.70 1.80 1.90 2.00 2.10 % -10 90 0.80 0.90 1.00 1.10 1.20 1.30 1.40 1.50 1.60 1.70 1.80 1.90 2.00 2.10 % -10 90 0.80 0.90 1.00 1.10 1.20 1.30 1.40 1.50 1.60 1.70 1.80 1.90 2.00 2.10 % -10 90 0.80 0.90 1.00 1.10 1.20 1.30 1.40 1.50 1.60 1.70 1.80 1.90 2.00 2.10 % -10 90 031007005 Sm (Mn, 3x2) 1: TOF MS ES+ 366.112 0.05Da 126 Area 1.48;214.0901;8.31 031007002 Sm (Mn, 3x2) 1: TOF MS ES+ 366.112 0.05Da 88.8 Area 1.48;214.0888;5.44 031007005 Sm (Mn, 3x2) 1: TOF MS ES+ 388.094 0.05Da 5.64 Area 1.47;214.0901;0.30 031007002 Sm (Mn, 3x2) 1: TOF MS ES+ 388.094 0.05Da 6.70 Area 1.49;158.0269;0.41 Amoxocillin Ion guide 3.4 Amoxocillin Ion guide 1.6 Amoxocillin Na Ion guide 1.6 Amoxocillin Na Ion guide 3.4 +52.7% -26.8% Effect of the ion guide voltage on the analyte response